Dr Lal Pathlabs Ltd
Healthcare | Small Cap
Dr Lal Pathlabs Ltd. demonstrates exceptional financial health, characterized by outstanding profitability and robust growth. The company is highly effective at turning revenue into profit and is expanding its earnings and sales at an impressive rate. Its financial foundation is remarkably strong, with very low reliance on debt, which minimizes financial risk. The company also maintains a very strong capacity to cover its immediate financial obligations. A key area of mixed performance is in its operational efficiency; while it manages its inventory and customer payments very effectively, it is not generating as much sales from its long-term assets as it could be. There is also a potential concern regarding the sustainability of its dividend payments, as earnings do not appear to fully cover them. Overall, the company's strong profitability and growth paint a positive picture, supported by a secure financial structure.
Latest Report
View AllLatest News
View AllWhy Are Indians Dying Of Heart Attacks In Their 40s? Dr Arvind Lal Has Been Trying To Answer That For Decades
- Valuation MetricsHighly Overvalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio8.40
- Profitability Ratio10.00
- Efficiency Ratio7.33
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio9.60
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayBullish
- 1 WeekBullish
- 1 MonthBullish
Dr Lal Pathlabs Ltd. demonstrates exceptional financial health, characterized by outstanding profitability and robust growth. The company is highly effective at turning revenue into profit and is expanding its earnings and sales at an impressive rate. Its financial foundation is remarkably strong, with very low reliance on debt, which minimizes financial risk. The company also maintains a very strong capacity to cover its immediate financial obligations. A key area of mixed performance is in its operational efficiency; while it manages its inventory and customer payments very effectively, it is not generating as much sales from its long-term assets as it could be. There is also a potential concern regarding the sustainability of its dividend payments, as earnings do not appear to fully cover them. Overall, the company's strong profitability and growth paint a positive picture, supported by a secure financial structure.
Latest Report
View AllLatest News
View AllWhy Are Indians Dying Of Heart Attacks In Their 40s? Dr Arvind Lal Has Been Trying To Answer That For Decades
Overall Valuation Score
P/E RATIO (TTM)
53.95
Industry Median
31.45
Small Cap Median
31.45
P/E RATIO
54.29
P/B RATIO
10.91
Industry Median
3.67
Small Cap Median
3.67
P/S RATIO
9.95
Industry Median
3.31
Small Cap Median
3.31
Others
PEG RATIO
4.31
EV/EBITDA RATIO
31.35
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1635.8 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤30th Apr 26
Consolidated Financial Results (Unaudited/Audited) for the Quarter and Year Ended March 31, 2026
UNDEFINED SENTIMENT
Concall Report⬤3rd Feb 26
Q3 FY26 Earnings Conference Call Transcript
NEUTRAL SENTIMENT
Concall Report⬤31st Oct 25
Q2 H1 FY26 Earnings Conference Call Transcript
NEUTRAL SENTIMENT
The company is experiencing a period of outstanding growth across all major financial dimensions. Revenues, profits, and earnings per share are all expanding at an excellent rate. This comprehensive growth indicates strong market demand for its services, successful business strategies, and effective management. The expansion of its asset base suggests continued investment to support future growth. This strong upward trajectory is a very positive sign for the company's future prospects and its ability to create value for shareholders.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 32.01 | -3.35 | 10.41 | 10.51 | 12.27 |
| Operating Profit Growth Rate | 28.67 | -12.66 | 24.29 | 14.61 | 12.03 |
| Earnings Per Share (EPS) Growth | 18.3 | -30.74 | 49.48 | 36.04 | 3.4 |
| Asset Growth Rate | 41.06 | 1.71 | 2.98 | 10.55 | 15.96 |
| Net Income Growth Rate | 18.24 | -31.14 | 50.21 | 35.91 | 3.66 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial metrics reflect strong performance in creating shareholder value. Key indicators like earnings per share and book value per share are at excellent levels, showing robust profitability and a solid equity base behind each share. However, the scoring model flags the company's high level of capital expenditures as a negative. While heavy investment can be essential for future growth in the healthcare sector, this model penalizes the high cash outflow, presenting a conflicting view of this strategic choice.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 42.77 | 29.16 | 44.22 | 59.4 | 32.02 |
| Cash Earnings Per Share (Cash EPS) | 55.18 | 47.11 | 60.96 | 75.48 | 40 |
| Book Value Per Share | 180.84 | 200.72 | 222.77 | 258.69 | 149.35 |
| Dividend Per Share (DPS) | 6 | 6.02 | 0 | 0 | 24.41 |
| Capital Expenditures (CapEx) | 474 | 45 | 56 | 53 | 173 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability is outstanding across the board. It demonstrates a superior ability to convert revenue into profit at every level, from gross profit down to net income. Returns on equity, assets, and capital employed are all at excellent levels, indicating that management is highly effective at using the company's resources to generate profits. This high level of profitability is a core strength, providing the resources for growth, debt repayment, and returns to shareholders.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.71 | 16.86 | 20.88 | 22.59 | 22.44 |
| Return on Capital Employed (ROCE) | 29 | 18 | 25 | 29 | 28 |
| Return on Equity (ROE) | 23.32 | 14.47 | 19.58 | 22.64 | 20.33 |
| Return on Assets (ROA) | 23.94 | 20.56 | 24.82 | 25.73 | 24.86 |
| Operating Margin | 26.88 | 24.29 | 27.35 | 28.36 | 28.3 |
| Net Margin | 16.77 | 11.95 | 16.26 | 19.99 | 18.46 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency presents a mixed picture. On one hand, it is exceptionally efficient in managing its inventory and collecting payments from customers, indicating strong control over its working capital. This means products are sold quickly and cash is collected promptly. On the other hand, the company is not effectively using its fixed assets, like equipment and buildings, or its total capital to generate sales. This suggests that there are opportunities to derive more revenue from its substantial investments in infrastructure.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.52 | 1.55 | 1.81 | 2.11 | 2.2 |
| Inventory Turnover Ratio | 34.04 | 38.55 | 49.61 | 52.22 | 53.55 |
| Receivables Turnover Ratio | 27.46 | 25.86 | 30.09 | 29.83 | 27.77 |
| Days Sales in Inventory Ratio | 10.72 | 9.47 | 7.36 | 6.99 | 6.82 |
| Receivable Days | 13.29 | 14.11 | 12.13 | 12.24 | 13.14 |
| Capital Turnover Ratio | 1.13 | 1.04 | 1.11 | 1.06 | 1.02 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's ability to cover its financial obligations is a mixed story. On a positive note, its capacity to cover interest payments on its debt is exceptionally strong, thanks to its high earnings and low debt levels. This means there is virtually no risk of defaulting on its interest obligations. However, the company's ability to cover its dividend payments from its earnings appears weak. This suggests that the dividend policy may be aggressive relative to current profits, which could pose a risk to the sustainability of future dividend payouts.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 16.83 | 10.05 | 18.41 | 29.41 | 30.09 |
| Equity Dividend Coverage Ratio | 3.45 | 2.38 | 1.23 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency is in an exceptionally strong position. It relies very little on borrowed funds, with the vast majority of its assets being financed by owner's equity. This low level of debt translates to minimal financial risk and a very high capacity to withstand economic downturns. Creditors and investors would view this as a sign of supreme financial stability and long-term viability. The company is not burdened by significant interest payments, which frees up earnings for reinvestment or shareholder returns.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.19 | 0.14 | 0.08 | 0.07 | 0.07 |
| Debt to Equity Ratio | 0.23 | 0.16 | 0.09 | 0.08 | 0.08 |
| Equity Ratio | 0.81 | 0.86 | 0.92 | 0.93 | 0.93 |
| Debt To Asset Ratio | 0.15 | 0.11 | 0.07 | 0.06 | 0.06 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company exhibits an exceptionally strong liquidity position. It has a substantial cushion of cash and other liquid assets to meet its short-term financial obligations comfortably. This indicates a very low risk of facing a cash crunch in the near future. The ability to quickly convert assets into cash to pay off immediate debts is excellent. Cash generated from core business operations is also healthy and sufficient to cover its current liabilities, reinforcing its stable financial standing.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.83 | 2.05 | 2.52 | 3.17 | 3.33 |
| Quick Ratio | 1.72 | 1.98 | 2.43 | 3.08 | 3.23 |
| Cash Ratio | 1.27 | 1.48 | 1.89 | 2.19 | 2.07 |
| Operating Cash Flow Ratio | 0.92 | 1.01 | 1.22 | 1.49 | 1.45 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Dr Lal Pathlabs Ltd | 8.79 | 54.29 | Highly Overvalued | 782.00 | 30.32 | 510.00 |
| 2 | Vijaya Diagnostic Centre Ltd | 8.44 | 81.15 | Neutral | 337.00 | 17.33 | 173.00 |
| 3 | Indegene Ltd | 7.58 | 31.98 | Neutral | 619.00 | 8.80 | 401.00 |
Dr. Lal Pathlabs' management demonstrates strong capabilities in operational efficiency and financial prudence, evidenced by consistently high operating margins, an outstanding negative cash conversion cycle, and a robust balance sheet with low, declining debt. Capital returns (ROCE/ROE) remain strong. However, the assessment is moderated to 'Orange' due to notable volatility in recent growth, with a significant profit decline in FY23 followed by a sharp recovery in FY24. Additionally, a long-term declining trend in ROCE from historical highs and a recent suspension of dividend payouts in FY24 (a departure from a consistent history) indicate areas of weakness or strategic shifts that temper the overall positive impression.
Financial Performance & Growth
The company's financial performance shows strong long-term compounded growth in sales (10Y: 13%) and profit (10Y: 15%). Operating profit margins have been consistently robust, standing at 27% in FY24. However, the growth trajectory has been marked by significant volatility recently. After strong growth in FY22, the company saw a sales contraction of -3.4% in FY23 before recovering to 10.4% growth in FY24. Profit growth has been even more volatile, with a sharp decline of -31% in FY23 followed by a strong rebound of 50% in FY24. This inconsistency in year-on-year performance, particularly the dip in FY23, points to challenges in maintaining a stable growth path, making the overall performance average despite strong long-term metrics.
| Metric | 2018–2020 (Avg) | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Sales Growth (%) | 13.4% | 18.9% | 32.0% | -3.4% | 10.4% |
| Profit Growth (%) | 13.3% | 29.0% | 18.0% | -31.0% | 50.0% |
Capital Efficiency & Returns
Management has demonstrated good capital efficiency, consistently delivering high returns. The Return on Equity (ROE) stands at a strong 23% in the last year. The current Return on Capital Employed (ROCE) is also strong at 25%. A standout feature is the excellent working capital management, reflected in a consistently negative Cash Conversion Cycle (CCC), which was -108 days in FY24. This indicates the company receives cash from customers well before paying its suppliers, a significant operational strength. However, the rating is 'Good' instead of 'Excellent' because the ROCE has been on a declining trend from its historical highs. While current levels are still strong, this downward trend indicates diminishing capital productivity over the long term.
| Metric | 2015–2017 (Avg) | 2018–2020 (Avg) | 2021-2023 (Avg) | 2024 |
|---|---|---|---|---|
| ROCE (%) | 46.0% | 35.0% | 26.7% | 25.0% |
| ROE (Last Year) | - | - | - | 23.0% |
| CCC (Days) | -41 | -54 | -73 | -108 |
Financial Health & Prudence
The company exhibits excellent financial health and prudent management of its balance sheet. Debt levels are very low, with the Debt-to-Equity ratio standing at a mere 0.13 in FY24. Management has actively worked to reduce leverage; borrowings have decreased from a high of ₹533 Cr in March 2022 to ₹247 Cr in March 2024. Consequently, the company's ability to service its debt is extremely strong, as shown by a high Interest Coverage Ratio of 21x in FY24, calculated as Operating Profit over Interest. A notable point is the suspension of dividend payout in FY24, which breaks a long history of sharing profits with shareholders, including a 42% payout ratio in FY23.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Borrowings (₹ Cr) | 150 | 533 | 420 | 247 |
| Debt/Equity Ratio | 0.12 | 0.36 | 0.25 | 0.13 |
| Interest Coverage | 27.3x | 18.7x | 12.9x | 21.0x |
Shareholding & Ownership Structure
The shareholding structure indicates strong alignment and investor confidence. Promoter holding is substantial at 54.60% as of March 2024. Although this shows a slight, gradual decline from 58.22% in 2017, it remains a significant stake. More importantly, institutional holding is both high and increasing. As of March 2024, Foreign Institutional Investors (FIIs) held 26.15% and Domestic Institutional Investors (DIIs) held 9.40%, for a combined institutional stake of 35.55%. The DII holding, in particular, has seen a notable increase from 6.56% in the previous year, suggesting growing confidence from sophisticated domestic investors. This robust ownership by promoters and institutions provides a stable shareholder base.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Promoter Holding (%) | 55.23 | 55.23 | 55.03 | 54.60 |
| FII Holding (%) | 26.01 | 23.44 | 24.89 | 26.15 |
| DII Holding (%) | 7.52 | 6.83 | 6.56 | 9.40 |
The overall risk profile for Dr. Lal Pathlabs is moderate. Financial and accounting risks are minimal due to a very strong balance sheet, low debt, and high-quality earnings, as evidenced by strong cash flow conversion. However, the primary risk identified is significant business performance volatility. The sharp fluctuations in sales and profit growth in recent years create uncertainty around the company's future earnings trajectory. While the solid financial foundation provides a buffer against this volatility, the unpredictability in core business performance is a notable concern.
Business Performance Risk
The company exhibits a notable degree of business performance risk, stemming from significant volatility in its growth metrics. After a period of high growth, sales declined by 3.4% in FY23, and profit fell sharply by 31%. While FY24 saw a strong recovery with 10.4% sales growth and 50% profit growth, this whiplash effect indicates a high sensitivity to market dynamics, competitive pressures, or other external factors. This level of fluctuation creates uncertainty and makes future performance difficult to predict, posing a risk to consistent earnings and shareholder returns.
| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Sales Growth (%) | 18.9% | 32.0% | -3.4% | 10.4% |
| Profit Growth(%) | 29.0% | 18.0% | -31.0% | 50.0% |
Financial Risk
Financial risk for the company is very low. The balance sheet is strong, with a Debt-to-Equity ratio of just 0.13 as of March 2024. Borrowings are on a downward trend, having been reduced by over 50% from their peak in FY22. The company's ability to cover its interest obligations is robust, with an interest coverage ratio of 21 times its operating profit. This strong financial position provides a significant cushion against economic downturns and interest rate volatility.
Accounting Quality
The company's accounting quality appears to be of a high standard. A key indicator, the ratio of Cash Flow from Operations (CFO) to Operating Profit (OP), has been consistently strong. Based on the source data, this ratio has remained near or above 100% in recent years, standing at 110% in FY24. This demonstrates that the company is proficient at converting its reported profits into actual cash, which is a hallmark of high-quality earnings and transparent accounting practices.
| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CFO/OP (%) | 115% | 103% | 115% | 110% |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101646.54Bearish
- SMA 201647.86Bearish
- SMA 501632.99Bullish
- EMA 101642.46Bearish
- EMA 201644.91Bearish
- EMA 501632.66Bullish
- DEMA 101637.11Bullish
- DEMA 201646.40Bearish
- DEMA 501654.73Bearish
- TEMA 101634.40Bullish
- TEMA 201636.69Bullish
- TEMA 501662.23Bearish
- MACD-0.11Bearish
- ADX19.95Weak Trend
- IndicatorValueSignal
- RSI47.87Neutral
- CCI-99.11Neutral
- ROC 9-1.03Bearish
- ROC 14-0.67Bearish
- ROC 25-3.56Bearish
- Stoch K21.83Neutral
- Stoch D17.39Oversold
- IndicatorValueSignal
- BB Upper1667.24Neutral
- BB Middle1647.86Neutral
- BB Lower1628.48Neutral
- ATR19.73Low Volatility
- IndicatorValueSignal
- MFI48.93Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 101646.95Bearish
- SMA 201648.35Bearish
- SMA 501601.32Bullish
- EMA 101644.80Bearish
- EMA 201639.25Bearish
- EMA 501619.14Bullish
- DEMA 101644.49Bearish
- DEMA 201655.58Bearish
- DEMA 501641.19Bearish
- TEMA 101637.07Bullish
- TEMA 201652.52Bearish
- TEMA 501650.11Bearish
- MACD10.49Bearish
- ADX42.45Strong Trend
- IndicatorValueSignal
- RSI51.19Neutral
- CCI-39.92Neutral
- ROC 9-0.96Bearish
- ROC 14-3.67Bearish
- ROC 252.41Bullish
- Stoch K12.61Oversold
- Stoch D14.52Oversold
- IndicatorValueSignal
- BB Upper1723.71Neutral
- BB Middle1648.35Neutral
- BB Lower1572.99Neutral
- ATR29.32Low Volatility
- IndicatorValueSignal
- MFI19.77Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101644.26Bearish
- SMA 201609.75Bullish
- SMA 501610.63Bullish
- EMA 101636.08Bullish
- EMA 201621.10Bullish
- EMA 501594.51Bullish
- DEMA 101651.69Bearish
- DEMA 201642.34Bearish
- DEMA 501646.39Bearish
- TEMA 101649.42Bearish
- TEMA 201654.31Bearish
- TEMA 50N/AN/A
- MACD17.27Bullish
- ADX41.80Strong Trend
- IndicatorValueSignal
- RSI55.20Neutral
- CCI39.43Neutral
- ROC 92.08Bullish
- ROC 144.71Bullish
- ROC 254.11Bullish
- Stoch K35.52Neutral
- Stoch D37.37Neutral
- IndicatorValueSignal
- BB Upper1692.39Neutral
- BB Middle1609.75Neutral
- BB Lower1527.10Neutral
- ATR43.04Low Volatility
- IndicatorValueSignal
- MFI77.28Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 101609.39Bullish
- SMA 201598.67Bullish
- SMA 501543.17Bullish
- SMA 1001463.31Bullish
- SMA 2001500.78Bullish
- EMA 101620.86Bullish
- EMA 201603.73Bullish
- EMA 501552.29Bullish
- EMA 1001510.18Bullish
- EMA 2001489.98Bullish
- DEMA 101641.40Bearish
- DEMA 201635.04Bullish
- DEMA 501622.61Bullish
- DEMA 1001552.73Bullish
- DEMA 2001513.66Bullish
- TEMA 101652.98Bearish
- TEMA 201629.56Bullish
- TEMA 501657.87Bearish
- TEMA 1001601.89Bullish
- TEMA 2001518.32Bullish
- MACD23.45Bullish
- ADX25.85Strong Trend
- IndicatorValueSignal
- RSI58.22Neutral
- CCI86.18Neutral
- ROC 143.71Bullish
- ROC 252.23Bullish
- Stoch K49.54Neutral
- Stoch D53.30Neutral
- IndicatorValueSignal
- BB Upper1668.51Neutral
- BB Middle1598.67Neutral
- BB Lower1528.84Neutral
- ATR61.53Low Volatility
- IndicatorValueSignal
- MFI83.01Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 201448.14Bullish
- SMA 501502.32Bullish
- EMA 201492.27Bullish
- EMA 501473.42Bullish
- DEMA 201528.61Bullish
- DEMA 501493.27Bullish
- TEMA 201575.32Bullish
- TEMA 501482.40Bullish
- MACD35.61Bullish
- ADX20.59Weak Trend
- IndicatorValueSignal
- RSI57.00Neutral
- CCI52.41Neutral
- ROC 1417.76Bullish
- ROC 2515.08Bullish
- Stoch K69.16Neutral
- Stoch D72.64Neutral
- IndicatorValueSignal
- BB Upper1666.84Neutral
- BB Middle1448.13Neutral
- BB Lower1229.43Neutral
- ATR103.13High Volatility
- IndicatorValueSignal
- MFI78.39Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 61429.78Bullish
- SMA 121488.29Bullish
- SMA 241471.35Bullish
- EMA 61461.93Bullish
- EMA 121456.49Bullish
- EMA 241429.00Bullish
- DEMA 61471.89Bullish
- DEMA 121470.53Bullish
- DEMA 241494.74Bullish
- TEMA 61492.11Bullish
- TEMA 121454.89Bullish
- TEMA 241480.31Bullish
- MACD107.68Bearish
- ADX20.17Weak Trend
- IndicatorValueSignal
- RSI56.34Neutral
- CCI105.41Overbought
- ROC 2535.50Bullish
- ROC 5023.14Bullish
- Stoch K54.20Neutral
- Stoch D59.13Neutral
- IndicatorValueSignal
- BB Upper1697.16Neutral
- BB Middle1450.83Neutral
- BB Lower1204.50Neutral
- ATR191.98High Volatility
- IndicatorValueSignal
- MFI60.44Neutral